Approaching the asymptote: obstacles and opportunities for nanomedicine in cardiovascular disease
Current Atherosclerosis Reports, 05/04/2012
Goonewardena SN – Authors must understand the principles governing the interactions between nanomaterials and biological systems. This review explores nanoparticle attributes and how they can be leveraged to develop novel molecular tools for the diagnosis and treatment of cardiovascular disease.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.